Bayer has secured preliminary court approval for a $7.25 billion settlement to resolve approximately 65,000 remaining claims related to its Roundup weedkiller. Judge Timothy Boyer in St.
Louis granted preliminary approval on March 4, 2026, marking a significant milestone in the litigation that has spanned years and resulted in thousands of lawsuits from individuals who claim Roundup caused non-Hodgkin’s lymphoma. The settlement represents Bayer’s commitment to resolving these ongoing disputes while maintaining that it does not admit liability or wrongdoing for the product. This article walks you through what the settlement means, who qualifies, what you need to do if you’re eligible, and important deadlines you cannot miss.
Table of Contents
- What Does Bayer’s $7.25 Billion Settlement Cover?
- Who Is Eligible and How Much Can Individual Claimants Receive?
- The Court Approval and What Happens Next
- Critical Deadlines You Must Know
- Understanding the “No Admission of Liability” Component
- How Settlement Payouts Will Be Calculated
- What Happens at Final Approval and Beyond
- Conclusion
- Frequently Asked Questions
What Does Bayer’s $7.25 Billion Settlement Cover?
The $7.25 billion settlement addresses claims from approximately 65,000 individuals who have pending cases in federal and state courts against Bayer related to Roundup exposure and alleged health injuries. The settlement is designed to be comprehensive, covering both currently filed claims and providing a mechanism for resolving future claims over an extended period. This is not Bayer’s first settlement related to Roundup—the company has previously settled other litigation—but this particular agreement represents one of the largest remaining settlements for unresolved claims in the litigation pipeline.
The settlement funds will be distributed over up to 21 years, which is crucial to understand because it means payments will not all occur at once. Instead, the settlement establishes a long-term funding structure that allows Bayer to meet its obligations while enabling the settlement administrator to pay eligible claimants as their cases are reviewed and approved. The settlement covers claims alleging that exposure to Roundup caused or contributed to non-Hodgkin’s lymphoma, the specific health condition at the center of the litigation.
Who Is Eligible and How Much Can Individual Claimants Receive?
Eligibility for the Bayer Roundup settlement generally includes individuals who were exposed to Roundup and subsequently developed non-Hodgkin’s lymphoma. The settlement provides for individual compensation ranging from approximately $6,000 to $165,000 per class member, though the actual amount you receive will depend on several factors specific to your case. These factors typically include the strength of your claim, your exposure history, your medical diagnosis, and how long you were exposed to the product. Not all eligible individuals will receive the same payment—the settlement includes a claims process that evaluates each case individually.
However, it’s important to note that the settlement does not require Bayer to admit liability or wrongdoing. This means the company is not conceding that Roundup actually caused the health conditions being claimed. Instead, the settlement is a resolution of the litigation without such an admission. This distinction matters if you’re considering whether to participate, because it means the settlement is reached as a business decision to resolve disputes rather than as an acknowledgment of the product’s culpability.
The Court Approval and What Happens Next
Judge Timothy Boyer’s preliminary approval on March 4, 2026 was a crucial step, but it was only the beginning of the process. Preliminary approval means the judge has determined that the settlement terms appear to be fair and reasonable enough to move forward to the next stage. However, before the settlement becomes final, there are additional steps that must be completed.
The settlement will now move into a claims notification period where eligible individuals will be informed of the settlement and given information about how to participate or object. Following preliminary approval, Bayer was required to deposit an initial $500 million into the settlement fund within 10 days of the court order. This money covers notification expenses, administrative costs of running the settlement, and ensures there is immediate funding available to begin the process. The remaining funds will be deployed according to the settlement payment schedule over the 21-year period, ensuring that claimants will be paid as their claims are processed.
Critical Deadlines You Must Know
If you believe you are eligible for this settlement, understanding the deadlines is absolutely essential—missing these dates could result in losing your opportunity to participate or protect your rights. Class members have 90 days from the preliminary approval date (until approximately June 4, 2026) to decide whether to participate in the settlement, file an objection to the settlement terms, or opt out entirely. These are not flexible deadlines; once they pass, you will generally not have a second chance to join the settlement.
If you do nothing by the deadline, you may still be included as a settlement member, which means you’ll be bound by the settlement terms. If you want to object to the settlement or opt out to pursue your own lawsuit, you must take action before the 90-day window closes. It’s also important to understand that opting out means you cannot later participate in this settlement if you change your mind. The settlement administrator will provide detailed instructions on how to submit a claim, object, or opt out, and you should watch for notification materials that explain your options and the specific procedures.
Understanding the “No Admission of Liability” Component
One of the most significant aspects of the Bayer settlement is that it does not require the company to admit liability or acknowledge that Roundup caused anyone’s health conditions. This can be confusing for settlement members who believe the product caused their illness. The “no admission” language means Bayer is not saying “we were wrong” or “our product is dangerous.” Instead, the company is saying “we are resolving these disputes to move forward,” without acknowledging the underlying claims. This distinction has practical implications.
If you participate in the settlement, you are accepting compensation without a court determination or admission that Roundup was the cause of your condition. Some individuals find this acceptable as a way to reach closure and receive compensation without the cost and uncertainty of continued litigation. Others may prefer to continue fighting in court if they believe establishing liability is important to them. Understanding whether this “no admission” approach works for you is a key factor in deciding whether to opt out.
How Settlement Payouts Will Be Calculated
While individual settlements range from approximately $6,000 to $165,000, the exact amount you receive will be determined through a structured settlement matrix that evaluates specific criteria about your case. The settlement administrator will review information such as the strength of your medical evidence showing non-Hodgkin’s lymphoma, your documented exposure to Roundup, the duration of your exposure, and other relevant factors. For example, an individual with a clear medical diagnosis, extensive exposure documentation, and long-term use of the product might receive a higher settlement amount than someone with limited exposure history or weaker medical evidence.
The settlement process will require you to submit documentation supporting your claim. This typically includes medical records confirming your diagnosis, evidence of Roundup use (such as receipts, testimony about products purchased, or documentation of exposure at a workplace), and sometimes expert medical reports. The settlement administrator will review these materials and make a determination about your payment amount. If you disagree with the determination, there is often an objection or review process available.
What Happens at Final Approval and Beyond
After the current notification period ends around June 4, 2026, the settlement will move toward final approval by the court. At final approval stage, Judge Timothy Boyer will consider whether the settlement should be formally approved. Final approval typically happens several months after the preliminary approval deadline, though exact timing can vary. Once final approval is granted, the claims process will move into full operation, and the settlement administrator will begin reviewing and paying individual claims.
The 21-year funding period for the settlement means that payouts will continue for many years into the future. This extended timeline allows Bayer to manage its financial obligation while ensuring that all eligible claimants have an opportunity to receive compensation. If you are approved for a settlement payment, you will be notified of your award amount and payment method. Some settlements provide lump-sum payments, while others may structure payments differently—the specific terms will be detailed in the settlement documents and administrator communications.
Conclusion
Bayer’s $7.25 billion Roundup settlement represents a significant development for the approximately 65,000 individuals with pending claims related to the herbicide. The preliminary approval granted on March 4, 2026 sets in motion a process that will ultimately provide compensation to eligible claimants, though the “no admission of liability” component means the settlement does not establish that Roundup caused any health conditions. The key to protecting your interests is understanding your options—whether to participate, opt out, or object—and meeting the June 4, 2026 deadline to make your election.
If you believe you may be eligible for this settlement, act promptly to gather your documentation and watch for official notification from the settlement administrator. The compensation amounts ranging from $6,000 to $165,000 represent substantial funds, but only if you take the necessary steps to submit your claim and participate in the process. Do not miss the deadlines, and make sure you understand what participation means for your legal rights before making your decision.
Frequently Asked Questions
If I participate in the settlement, can I still sue Bayer separately?
If you participate in this settlement without opting out, you will generally not be able to pursue a separate lawsuit against Bayer for the same claims. This is a fundamental consequence of participating in a class action settlement.
What does “no admission of liability” mean for me as a claimant?
It means Bayer is not admitting that Roundup caused your condition. You are accepting a settlement payment without the company conceding that its product was responsible for your illness.
What is the deadline for deciding whether to participate?
You have until approximately June 4, 2026 (90 days from March 4, 2026) to decide whether to participate, opt out, or object to the settlement.
How long will it take to receive my settlement payment?
Timeline varies based on how quickly you submit your claim materials and how long the settlement administrator takes to review them. With over 65,000 claims, processing can take several months to over a year in some cases.
If the settlement says payments extend over 21 years, will I have to wait 21 years to get paid?
No. The 21-year period refers to the total funding timeline for all claims, not individual payment timelines. Individual payments will be made as claims are approved, which typically happens much sooner.
How do I know if I’m eligible for the settlement?
You must have been exposed to Roundup and subsequently developed non-Hodgkin’s lymphoma. You will need to submit medical documentation and evidence of Roundup exposure.